Till Örebro universitet

oru.seÖrebro universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
Department of Clinical Sciences, Lund University Diabetes Center, Lund University, Malmö, Sweden; Department of Nutrition, Harvard School of Public Health, Boston MA, USA.
Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Akademiska Sjukhuset, Uppsala, Sweden; George Institute for Global Health, Camperdown NSW, Australia; Medical Sciences, Uppsala University, Uppsala, Sweden.
Visa övriga samt affilieringar
2021 (Engelska)Ingår i: Journal of Internal Medicine, ISSN 0954-6820, E-ISSN 1365-2796, Vol. 290, nr 3, s. 602-620Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine (GDPM) - may help optimize medical practice. Here, we provide a comprehensive review of GDPM of complex diseases across major medical specialties. We focus on technological readiness: how rapidly a test can be implemented into health care. Although these areas of medicine are diverse, key similarities exist across almost all areas. Many medical areas have, within their standards of care, at least one GDPM test for a genetic variant of strong effect that aids the identification/diagnosis of a more homogeneous subset within a larger disease group or identifies a subset with different therapeutic requirements. However, for almost all complex diseases, the majority of patients do not carry established single-gene mutations with large effects. Thus, research is underway that seeks to determine the polygenic basis of many complex diseases. Nevertheless, most complex diseases are caused by the interplay of genetic, behavioural and environmental risk factors, which will likely necessitate models for prediction and diagnosis that incorporate genetic and non-genetic data.

Ort, förlag, år, upplaga, sidor
Blackwell Science Ltd. , 2021. Vol. 290, nr 3, s. 602-620
Nyckelord [en]
complex disease, genomics, precision diagnostics, precision medicine, precision prevention, precision treatment
Nationell ämneskategori
Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi
Identifikatorer
URN: urn:nbn:se:oru:diva-93115DOI: 10.1111/joim.13330ISI: 000669025500001PubMedID: 34213793Scopus ID: 2-s2.0-85109326832OAI: oai:DiVA.org:oru-93115DiVA, id: diva2:1580806
Forskningsfinansiär
Vetenskapsrådet, D0886501 2018-02837 2014-03352 2009-1039 2018-03307CancerfondenKnut och Alice Wallenbergs StiftelseKarolinska Institutets ForskningsstiftelseRadiumhemmets forskningsfonderHjärt-LungfondenStiftelsen för strategisk forskning (SSF), 15-0067Novo NordiskReumatikerförbundetSvenska läkaresällskapet
Anmärkning

Funding Agencies:

SciLifeLab 

United States Department of Health & Human Services

National Institutes of Health (NIH) - USA

NIH National Institute of Mental Health (NIMH)MH077139 MH1095320

European Commission 610307 733161 825843

European Research Council (ERC)

European Commission CoG-2015_681742_NASCENT

Strategic Research Area Epidemiology at Karolinska Institutet 

Vth 80-year Foundation 

Clinical Research Support (Avtal om Läkarutbildning och Forskning) 

Swedish government  

County councils  

ALF-agreement 

IMI2 Joint Undertaking 115974

European Federation of Pharmaceutical Industries and Associations with JDRF  

H2020 Program ERA PerMed JTC 2018 Call (VR) 2018-05619

Tillgänglig från: 2021-07-16 Skapad: 2021-07-16 Senast uppdaterad: 2023-06-02Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Halfvarson, JonasRepsilber, DirkOresic, Matej

Sök vidare i DiVA

Av författaren/redaktören
Halfvarson, JonasRepsilber, DirkOresic, Matej
Av organisationen
Institutionen för medicinska vetenskaper
I samma tidskrift
Journal of Internal Medicine
Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 68 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf